| LINE ITEM (USD / %) | FY 2025
FILED 2025-06-30 | FY 2024
FILED 2024-06-30 | FY 2023
FILED 2023-06-30 |
|---|---|---|---|
| Revenue (Total Sales) | $769.3M | $728.2M | $795.0M |
| YoY Revenue Growth % | +5.6% | -8.4% | — |
| Gross Profit | $39.7M | $40.5M | — |
| Gross Margin % | 5.2% | 5.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$35.1M | -$30.1M | -$52.9M |
| Operating Margin % | -4.6% | -4.1% | -6.7% |
| Net Income (GAAP) | -$29.5M | -$25.0M | -$52.4M |
| EBITDA (Normalized) | -$28.9M | -$24.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $117.5M | $72.6M | $10.2M |
| Capital Expenditures (CapEx) | $7.7M | $7.0M | — |
| Free Cash Flow (FCF) | $109.8M | $65.6M | $10.2M |
| FCF Margin % | 14.3% | 9.0% | 1.3% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $199.0M | $156.8M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $137.6M | $151.9M | — |